Statins May Benefit Patients With Hemorrhagic Stroke

Share this content:
Statins May Benefit Patients With Hemorrhagic Stroke
Statins May Benefit Patients With Hemorrhagic Stroke

(HealthDay News) — Patients taking statin medication while in the hospital for a hemorrhagic stroke are more than four times more likely to survive than people who aren't taking the drugs, according to a new study. The findings were published in JAMA Neurology.

Previous research has shown that statin medications help after ischemic strokes, lead author, Alexander Flint, MD, PhD, the medical director of neuroscience quality at Kaiser Permanente in Redwood City, California, told HealthDay. But, he added, there have been conflicting findings about statin use in hemorrhagic strokes. 

The goal of this study was to help shed light on the best approach for those patients. Flint and colleagues examined the medical records of almost 3,500 people treated for hemorrhagic strokes at 20 Kaiser Permanente hospitals in Northern California over a decade.

Patients who took statins in the hospital were much more likely to be alive after 30 days and more likely to leave the hospital for home or a rehabilitation facility, according to the data. 

The researchers also found that when patients who had been taking statins prior to their hemorrhagic stroke were taken off statins in the hospital, their odds of dying increased by 84%.

It's not clear how statins may be so helpful to stroke patients, according to Flint. 

"It's unlikely that the cholesterol-lowering effects of the statins are responsible, if only because they simply aren't fast enough to explain better outcomes like discharge to home," Flint said. 

The findings from this study aren't considered definitive because it wasn't designed to prove that the statin treatment directly caused the lower risk of death.

Reference

  1. Flint AC et al. JAMA Neurol. 2014;doi:10.1001/jamaneurol.2014.2124.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters



CME Focus